Cargando…
Carbetocin in comparison with oxytocin in several dosing regimens for the prevention of uterine atony after elective caesarean section in the Netherlands
PURPOSE: The aim of the study was to compare the prophylactic effects of carbetocin with those of oxytocin for the prevention of uterine atony in patients undergoing elective caesarean section (CS) in the Netherlands. The primary endpoint was the need for additional uterotonic medication. METHODS: E...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3655222/ https://www.ncbi.nlm.nih.gov/pubmed/23329341 http://dx.doi.org/10.1007/s00404-012-2693-8 |
_version_ | 1782269848909250560 |
---|---|
author | Holleboom, C. A. G. van Eyck, J. Koenen, S. V. Kreuwel, I. A. M. Bergwerff, F. Creutzberg, E. C. Bruinse, H. W. |
author_facet | Holleboom, C. A. G. van Eyck, J. Koenen, S. V. Kreuwel, I. A. M. Bergwerff, F. Creutzberg, E. C. Bruinse, H. W. |
author_sort | Holleboom, C. A. G. |
collection | PubMed |
description | PURPOSE: The aim of the study was to compare the prophylactic effects of carbetocin with those of oxytocin for the prevention of uterine atony in patients undergoing elective caesarean section (CS) in the Netherlands. The primary endpoint was the need for additional uterotonic medication. METHODS: Each of the five participating Dutch hospitals treated 50–100 term patients with 100 μg of intravenous carbetocin on prescription. Each centre retrieved charts of 250 patients treated with oxytocin according to the hospital’s policy for the prevention of uterine atony (oxytocin bolus 5 IU, bolus 10 IU or bolus 5 IU followed by 10 IU in 2 h). RESULTS: In the carbetocin group 462 subjects were included and in the oxytocin group 1,122. The proportion of subjects needing additional uterotonic treatment was 3.1 % (95 % CI 1.7–5.1 %) after carbetocin and 7.2 % (5.8–8.9 %) after oxytocin; relative risk 0.41 (0.19–0.85); p = 0.0110. Carbetocin was most effective compared with the oxytocin 5 IU bolus subgroup with less need for additional uterotonic medication (3.1 vs. 9.3 %, p = 0.0067) and blood transfusions (2.2 vs. 3.6 %, p = 0.0357). CONCLUSIONS: Compared with oxytocin, prophylaxis of uterine atony with carbetocin after an elective CS diminished the need for additional uterotonics by more than 50 %. |
format | Online Article Text |
id | pubmed-3655222 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Springer-Verlag |
record_format | MEDLINE/PubMed |
spelling | pubmed-36552222013-05-16 Carbetocin in comparison with oxytocin in several dosing regimens for the prevention of uterine atony after elective caesarean section in the Netherlands Holleboom, C. A. G. van Eyck, J. Koenen, S. V. Kreuwel, I. A. M. Bergwerff, F. Creutzberg, E. C. Bruinse, H. W. Arch Gynecol Obstet Maternal-Fetal Medicine PURPOSE: The aim of the study was to compare the prophylactic effects of carbetocin with those of oxytocin for the prevention of uterine atony in patients undergoing elective caesarean section (CS) in the Netherlands. The primary endpoint was the need for additional uterotonic medication. METHODS: Each of the five participating Dutch hospitals treated 50–100 term patients with 100 μg of intravenous carbetocin on prescription. Each centre retrieved charts of 250 patients treated with oxytocin according to the hospital’s policy for the prevention of uterine atony (oxytocin bolus 5 IU, bolus 10 IU or bolus 5 IU followed by 10 IU in 2 h). RESULTS: In the carbetocin group 462 subjects were included and in the oxytocin group 1,122. The proportion of subjects needing additional uterotonic treatment was 3.1 % (95 % CI 1.7–5.1 %) after carbetocin and 7.2 % (5.8–8.9 %) after oxytocin; relative risk 0.41 (0.19–0.85); p = 0.0110. Carbetocin was most effective compared with the oxytocin 5 IU bolus subgroup with less need for additional uterotonic medication (3.1 vs. 9.3 %, p = 0.0067) and blood transfusions (2.2 vs. 3.6 %, p = 0.0357). CONCLUSIONS: Compared with oxytocin, prophylaxis of uterine atony with carbetocin after an elective CS diminished the need for additional uterotonics by more than 50 %. Springer-Verlag 2013-01-18 2013 /pmc/articles/PMC3655222/ /pubmed/23329341 http://dx.doi.org/10.1007/s00404-012-2693-8 Text en © The Author(s) 2013 https://creativecommons.org/licenses/by/2.0/ Open AccessThis article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited. |
spellingShingle | Maternal-Fetal Medicine Holleboom, C. A. G. van Eyck, J. Koenen, S. V. Kreuwel, I. A. M. Bergwerff, F. Creutzberg, E. C. Bruinse, H. W. Carbetocin in comparison with oxytocin in several dosing regimens for the prevention of uterine atony after elective caesarean section in the Netherlands |
title | Carbetocin in comparison with oxytocin in several dosing regimens for the prevention of uterine atony after elective caesarean section in the Netherlands |
title_full | Carbetocin in comparison with oxytocin in several dosing regimens for the prevention of uterine atony after elective caesarean section in the Netherlands |
title_fullStr | Carbetocin in comparison with oxytocin in several dosing regimens for the prevention of uterine atony after elective caesarean section in the Netherlands |
title_full_unstemmed | Carbetocin in comparison with oxytocin in several dosing regimens for the prevention of uterine atony after elective caesarean section in the Netherlands |
title_short | Carbetocin in comparison with oxytocin in several dosing regimens for the prevention of uterine atony after elective caesarean section in the Netherlands |
title_sort | carbetocin in comparison with oxytocin in several dosing regimens for the prevention of uterine atony after elective caesarean section in the netherlands |
topic | Maternal-Fetal Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3655222/ https://www.ncbi.nlm.nih.gov/pubmed/23329341 http://dx.doi.org/10.1007/s00404-012-2693-8 |
work_keys_str_mv | AT holleboomcag carbetocinincomparisonwithoxytocininseveraldosingregimensforthepreventionofuterineatonyafterelectivecaesareansectioninthenetherlands AT vaneyckj carbetocinincomparisonwithoxytocininseveraldosingregimensforthepreventionofuterineatonyafterelectivecaesareansectioninthenetherlands AT koenensv carbetocinincomparisonwithoxytocininseveraldosingregimensforthepreventionofuterineatonyafterelectivecaesareansectioninthenetherlands AT kreuweliam carbetocinincomparisonwithoxytocininseveraldosingregimensforthepreventionofuterineatonyafterelectivecaesareansectioninthenetherlands AT bergwerfff carbetocinincomparisonwithoxytocininseveraldosingregimensforthepreventionofuterineatonyafterelectivecaesareansectioninthenetherlands AT creutzbergec carbetocinincomparisonwithoxytocininseveraldosingregimensforthepreventionofuterineatonyafterelectivecaesareansectioninthenetherlands AT bruinsehw carbetocinincomparisonwithoxytocininseveraldosingregimensforthepreventionofuterineatonyafterelectivecaesareansectioninthenetherlands |